稳心颗粒联合替格瑞洛治疗急性冠状动脉 综合征 PCI 术后心绞痛的疗效
CSTR:
作者:
作者单位:

(河南省第二人民医院,河南 郑州 451100)

作者简介:

魏亚倩,女,主治医师,主要研究方向是心血管疾病。

通讯作者:

中图分类号:

R 541

基金项目:


Efficacy of Wenxin Granule Combined with Ticagrelor in the Treatment of Angina Pectoris after PCI of Acute Coronary Syndrome
Author:
Affiliation:

(Henan Second Provincial People's Hospital, Henan Zhengzhou 451100)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    〔摘 要〕 目的:探究稳心颗粒联合替格瑞洛对急性冠状动脉综合征经皮冠状动脉介入治疗(PCI)术后心绞痛患 者血管内皮功能、心电图及氧化应激水平的影响。方法:选取河南省第二人民医院 2018 年 1 月至 2020 年 3 月期间收 治的 198 例急性冠状动脉综合征 PCI 术后心绞痛患者,按照随机数字表法分为对照组和观察组,各 99 例。其中对照 组患者给予替格瑞洛治疗,观察组患者给予稳心颗粒联合替格瑞洛治疗。比较两组患者每日硝酸甘油用量、症状持续 时间及胸闷、胸痛评分,血管内皮相关指标〔一氧化氮(NO)、血管扩张功能(FMD)、内皮素 1(ET–1)〕,心 电图改善有效率,氧化应激水平〔超氧化物歧化酶(SOD)、丙二醛(MDA)、一氧化氮合酶(NOS)〕,心肌损 伤标志物〔肌酸激酶同工酶 MB(CK–MB)、肌钙蛋白 Ⅰ(cTnI)〕。结果:治疗 6 个月后两组患者每日硝酸甘油用量、 症状持续时间及胸闷、胸痛评分较治疗前均明显降低,且治疗 6 个月后观察组患者每日硝酸甘油用量、症状持续时间 及胸闷、胸痛评分低于对照组,差异具有统计学意义(P < 0.05)。治疗 3 个月后、治疗 6 个月后两组患者 FMD、 NO、SOD、NOS 水平均有不同程度升高,且治疗 3 个月后、6 个月后观察组患者 FMD、NO、SOD、NOS 水平高于 对照组,差异具有统计学意义(P < 0.05)。治疗 3 个月后、6 个月后两组患者 ET–1、MDA、CK–MB、cTnI 水平均 有不同程度降低,且治疗 3 个月后、6 个月后观察组患者 ET–1、MDA、CK–MB、cTnI 水平低于对照组,差异具有 统计学意义(P < 0.05)。观察组患者心电图改善有效率为 92.93 %,高于对照组的 80.81 %,差异具有统计学意义 (P < 0.05)。结论:稳心颗粒联合替格瑞洛治疗急性冠状动脉综合征 PCI 术后心绞痛可有效减轻患者胸痛等临床症 状,改善心脏功能,可能与稳心颗粒联合替格瑞洛能够调节血管内皮功能及氧化应激水平,减轻心肌损伤有关。

    Abstract:

    〔Abstract〕 Objective To investigate the effects of Wenxin granule combined with ticagrelor on vascular endothelial function, electrocardiogram and oxidative stress in patients with angina pectoris after percutaneous coronary intervention (PCI) for acute coronary syndrome. Methods A total of 198 patients with angina pectoris after PCI who were admitted to Henan Second Province People's Hospital from January 2018 to March 2020 were divided into a control group and an observation group according to random number table method, with 99 cases in each group. The control group was treated with ticagrelor, and the observation group was treated with Wenxin granule combined with ticagrelor. Daily nitroglycerin dosage, symptom duration, chest distress and chest pain scores, vascular endothelial related indicators [nitric oxide (NO), vascular dilatation function (FMD), endothelin 1 (ET-1)], ecg improvement efficiency were compared between the two groups. Oxidative stress levels [superoxide dismutase (SOD), malondialdehyde (MDA), nitric oxide synthase (NOS)], markers of myocardial injury [creatine kinase isoenzyme MB (CK-MB), troponinI (cTnI)]. Results After 6 months of treatment, the daily nitroglycerin dosage, symptom duration and chest distress and chest pain score in the two groups were significantly reduced compared with before treatment, and the daily nitroglycerin dosage, symptom duration and chest distress and chest pain score in the observation group were lower than those in the control group after 6 months of treatment, the differences were statistically significant (P < 0.05). After 3 and 6 months after treatment, FMD, the levels of NO, SOD and NOS in the two groups were increased to varying degrees, and after 3 and 6 months of treatment, FMD, the levels of NO, SOD and NOS in the observation group were higher than those in the control group, the differences were statistically significant (P < 0.05). After 3 and 6 months of treatment, the levels of ET-1, MDA, CK-MB and cTnI in the two groups were decreased to varying degrees, and after 3 and 6 months of treatment, the levels of ET-1, MDA, CK-MB and cTnI in the observation group were lower than those in the control group, with statistical significances (P < 0.05). The effective rate of ecg improvement in the observation group was 92.93%, which was higher than 80.81% in the control group, the difference was statistically significant (P < 0.05). ConclusionWenxin granule combined with ticagrelor in the treatment of angina pectoris after PCI in patients with acute coronary syndrome can effectively reduce the clinical symptoms such as chest pain and improve cardiac function, it may be related to the regulation of vascular endothelial function and oxidative stress level, and the reduction of myocardial injury.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2022-04-14
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-08-24
  • 出版日期:
文章二维码
特别声明

近期有不法分子冒充我刊名义给作者打电话或发邮件,编造各种理由要求添加微信或QQ、伪造复制我刊编辑部公章发放假冒录用通知书等等各种方式试图骗取作者钱财。为强化编辑部工作规范,加强单位公章管理,维护作者的正当权益和财产利益, 我刊在此郑重声明:(1)编辑部与作者沟通方式为电话和邮件,在本刊唯一官方网站(http:/szzxyjhzz.szrch.com)“联系我们”下拉菜单,或者网站最下端信息栏可以查询),绝对不会要求作者添加微信或QQ。 (2)自2025年2月1日起,注销废除“深圳中西医结合杂志编辑部”电子公章;我刊稿件录用通知调整为加盖编辑部实体公章的纸质文件或其扫描件,录用稿件仅收取合理版面制作费和审稿费,收款单位为“深圳市第二人民医院”对公账户,其他加盖电子公章或涉及私人账户者均为伪造假冒。望广大作者提高警惕,谨防上当受骗。 《深圳中西医结合杂志》编辑部

关闭